A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models
Crossref DOI link: https://doi.org/10.1007/s40487-016-0031-1
Published Online: 2016-09-27
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hassan, Wafaa
Chitcholtan, Kenny
Sykes, Peter
Garrill, Ashley